SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Omni Bio Pharmaceutical Announces FDA IND Clearance for Alpha-1 Antitrypsin (AAT) Type 1 Diabetes Clinical Trial